Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

| Build smarter healthcare apps, faster. See how clinical data repositories help developers unlock clinical data and drive ...

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...

Thermo Fisher ( NYSE: TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data ...

From streaming video and syncing data to connecting applications, the cloud plays an increasingly pivotal role in helping ...

The complex and costly journey of oncology drug development is reliant on robust and comprehensive clinical data. Early-stage ...

Lower respiratory tract infections (LRTIs) are among the leading causes of illness and death in children worldwide. To better ...

Every year, millions of dollars are lost to delays and inefficiencies in utilization management, making it one of the most daunting obstacles impeding timely, a ...

ICH gives CGT developers a regulatory framework that finally matches the speed and flexibility their groundbreaking therapies ...

Get key insights from Bristol-Myers Squibb's Q3 2025 earnings call—growth highlights, raised guidance, and strategic pipeline updates.